Teva settles generic ‘pay-to-delay’ case for $1.2 billion

May 29, 2015
Sales and Marketing Cephalon, FTC, Teva, modafinil, provigil

Teva Pharmaceuticals has agreed to a $1.2 billion settlement for paying generic drug makers to delay challenging the patent for …

Merkel image

Sanofi plays host to German chancellor Angela Merkel

May 29, 2015
Manufacturing and Production, Medical Communications, Sales and Marketing France, Germany, Sanofi, angela, brett wells, merkel

German Chancellor Dr Angela Merkel met with Sanofi bosses in Frankfurt to discuss antibiotics and open a new manufacturing facility. …

screen_shot_2015-05-29_at_07

Huntingdon and Harlan names corporate marketing VP

May 29, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Huntingdon and Harlan, joseph bedford

UK’s Huntingdon Life Sciences and Harlan Laboratories has appointed Dr Joseph Bedford to serve as corporate vice president of global …

lilly

Two new diabetes drugs approved

May 28, 2015
Sales and Marketing Japan, Takeda, diabetes in China, lilly

Two new diabetes offerings from Lilly and Takeda are now available for patients in the US and Japan after they …

Eisai image

Eisai seeks new ALS drug approval

May 28, 2015
Sales and Marketing Eisai, Japan, als, mecobalamin

Eisai is hoping that existing neurology drug mecobalamin can be a new option for the difficult-to-treat condition amyotrophic lateral sclerosis …

valeant_pharma

Actavis and Valeant see FDA approval for IBS drugs

May 28, 2015
Sales and Marketing Actavis, FDA, IBS, Valeant, brett wells

Both Actavis and Valeant have been shown the green light for their respective irritable bowel syndrome (IBS) treatments from the …

NICE image

NICE sets out office for market access plans

May 28, 2015
Sales and Marketing ABPI, EMA, NHS, NICE, eams, market access

The UK healthcare watchdog NICE is to set up a new office for market access to advise pharma companies on …

patrizia_paterlini-brechot

Kayentis names four committee members

May 28, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Patrizia Paterlini-Brechot, Pierre-Olivier Goineau, Ronan Roussel, Stephen Senn, kayentis

French software solutions provider for clinical trials Kayentis has formed a strategic committee comprising four industry veterans.  Accepting director Guillaume …

Another Chinese health official arrested for corruption

May 27, 2015
Medical Communications, Sales and Marketing China, GSK, bribery, huang fenping, wang yu

A Chinese health official has been arrested on accusations of bribery as the country continues to crack down on corruption …

Novartis image

Novartis reveals ASCO plans

May 27, 2015
Sales and Marketing ASCO, GSK, Novartis

Novartis’ first ASCO conference since buying GlaxoSmithKline’s oncology business will be showcasing drugs from the acquisition. The two firms swapped …

amgen

Amgen cold sore virus drug shows ‘significant’ cancer benefit

May 27, 2015
Research and Development, Sales and Marketing Amgen, Cancer, cold sore, t-vec

Amgen is pinning its hopes on investigational viral treatment T-VEC following promising results from a ‘landmark’ skin cancer study. People …

fycompa

Eisai epilepsy drug sees EMA nod

May 27, 2015
Research and Development, Sales and Marketing Eisai, Fycompa, ema. epilepsy

Eisai’s UK subsidiary has received a positive opinion from the European Medicines Agency for using Fycompa for the adjunctive treatment …

suresh_kumar

Sanofi appoints external affairs VP

May 27, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, suresh kumar

Sanofi has said Suresh Kumar is to join the French pharma giant on its executive committee and become executive vice …

PrimeVigilance and Sound Opinion join forces

May 26, 2015
acquisition, medical information, primevigilance

Ergomed plc, the parent company of PrimeVigilance, has acquired Sound Opinion, one of the UK’s leading Medical Information (MI) service …

Jevtana image

Sanofi prostate cancer drug to remain on CDF

May 26, 2015
Sales and Marketing CDF, Cancer, NHS, Sanofi, list, prostate

Sanofi has reached an agreement with NHS England to reinstate its prostate cancer drug Jevtana on the Cancer Drugs Fund. …

otsuka image

Otsuka, ViiV and AstraZeneca named in ABPI code complaints

May 26, 2015
Medical Communications, Research and Development, Sales and Marketing ABPI, AstraZeneca, Otsuka, PMCPA, ViiV

A ‘senior male employee’ of Otsuka Pharmaceuticals “potentially brought the industry into disrepute” by plying a female healthcare professional with …

Amgen image

Amgen pulls out of psoriasis deal with AstraZeneca

May 26, 2015
Sales and Marketing Amgen, AstraZeneca, psoriasis

Amgen has ended its agreement with AstraZeneca to develop a new biologic for psoriasis, because of the likelihood of ‘restrictive …

medicago

Medicago invests big into plant-based vaccines

May 26, 2015
Manufacturing and Production, Sales and Marketing Canada, Quebec, medicago, vaccines

Canadian biotech Medicago is building a $245 million new production complex in Quebec to make more vaccines and therapeutics based …

elyse_seltzer

GSK head joins Nabriva as chief medical officer

May 26, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Elyse Seltzer, GSK, Nabriva Therapeutics

Austrian-based clinical stage biopharma firm Nabriva Therapeutics has appointed Dr Elyse Seltzer as its chief medical officer. Seltzer assumes the role …

cameron

After the UK general election, what’s next for pharma?

May 26, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA, election, medcity

In May the UK went to the polls and elected a Conservative government to replace the coalition that had been …

The Gateway to Local Adoption Series

Latest content